Soleno Therapeutics Stock Target Price and Analyst Consensus

SLNO Stock  USD 49.34  0.31  0.63%   
The current analyst and expert consensus on Soleno Therapeutics is Strong Buy, with 4 strong buy opinions. The current projected Soleno Therapeutics target price consensus is 74.29 with 7 analyst opinions. Check out Macroaxis Advice on Soleno Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.
The most common way Soleno Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Soleno Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Soleno Therapeutics. We strongly encourage you to use your own analysis of Soleno Therapeutics to validate this buy or sell advice. Soleno Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Soleno Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 3.3192.
Lowest Forecast
67.6
Highest Forecast
82.46
Target Price
74.29
At this time, Soleno Therapeutics' Pretax Profit Margin is very stable compared to the past year. As of the 15th of March 2025, Operating Profit Margin is likely to grow to 0.01, while Gross Profit is likely to drop (2.4 M). At this time, Soleno Therapeutics' Accounts Payable is very stable compared to the past year. As of the 15th of March 2025, Cash is likely to grow to about 92.3 M, while Short and Long Term Debt Total is likely to drop about 2.6 M.
  
It's important to approach Soleno Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Soleno Therapeutics Target Price Consensus

Soleno target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Soleno Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   7  Strong Buy
Most Soleno analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Soleno stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Soleno Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Soleno Therapeutics Target Price Projection

Soleno Therapeutics' current and average target prices are 49.34 and 74.29, respectively. The current price of Soleno Therapeutics is the price at which Soleno Therapeutics is currently trading. On the other hand, Soleno Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Soleno Therapeutics Market Quote on 15th of March 2025

Low Price48.44Odds
High Price50.23Odds

49.34

Target Price

Analyst Consensus On Soleno Therapeutics Target Price

Low Estimate67.6Odds
High Estimate82.46Odds

74.2857

Historical Lowest Forecast  67.6 Target Price  74.29 Highest Forecast  82.46
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Soleno Therapeutics and the information provided on this page.

Soleno Therapeutics Analyst Ratings

Soleno Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Soleno Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Soleno Therapeutics' financials, market performance, and future outlook by experienced professionals. Soleno Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Soleno Therapeutics price targets

Soleno Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Soleno Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Soleno Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Soleno Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Soleno Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Soleno Therapeutics is a key component of Soleno Therapeutics valuation and have some predictive power on the future returns of a Soleno Therapeutics.
Hype
Prediction
LowEstimatedHigh
45.8349.1552.47
Details
Intrinsic
Valuation
LowRealHigh
44.4163.1166.43
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
ESG Investing Idea
ESG Investing
Invested few shares
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 60 shares
Momentum Idea
Momentum
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 40 shares
Apparel Idea
Apparel
Invested over 40 shares
Casinos Idea
Casinos
Sold over 90 shares
Utilities Idea
Utilities
Invested over 90 shares
When determining whether Soleno Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Soleno Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Soleno Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Soleno Therapeutics Stock:
Check out Macroaxis Advice on Soleno Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.